CME
53
-3
MAS
56
-2
TXT
53
3
MLM
60
-7
NRG
59
-10
BAX
38
3
MOS
42
2
TROW
48
8
MCD
54
4
DLTR
38
14
VZ
34
-3
KMI
65
-4
CB
44
-3
WFC
71
-3
ROK
52
2
MDT
62
3
VRTX
43
-4
KMB
33
2
INTU
47
4
XYL
33
-4
CME
53
-3
MAS
56
-2
TXT
53
3
MLM
60
-7
NRG
59
-10
BAX
38
3
MOS
42
2
TROW
48
8
MCD
54
4
DLTR
38
14
VZ
34
-3
KMI
65
-4
CB
44
-3
WFC
71
-3
ROK
52
2
MDT
62
3
VRTX
43
-4
KMB
33
2
INTU
47
4
XYL
33
-4
Financhill
Back

Denali Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
50

DNLI
Denali Therapeutics

Last Price:
27.21
Seasonality Move:
18.4%
Sell
30

CATX
Perspective Therapeutics

Last Price:
12.11
Seasonality Move:
26.28%
Sell
50
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics a Buy, Sell or Hold?

  • The current Denali Therapeutics [DNLI] share price is $27.05. The Score for DNLI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $12.09. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DNLI Stock Price Chart

What is Denali Therapeutics's stock price today?

  • The Denali Therapeutics share price today is $27.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $12.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

DNLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 49.75 Sell
Chaikin Money Flow: 233319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.22 - 28.34) Sell
Bollinger Bands (100): (22.08 - 27.82) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 279101 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.94 - 13.14) Sell
Bollinger Bands (100): (11.23 - 14.35) Sell

DNLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.72 Buy
20-day SMA: 26.88 Buy
50-day SMA: 27.32 Sell
200-day SMA: 21.76 Buy
8-day EMA: 26.8 Buy
20-day EMA: 27.05 Sell
50-day EMA: 26.68 Buy
200-day EMA: 23.68 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.78 Buy
20-day SMA: 12.43 Sell
50-day SMA: 13.5 Sell
200-day SMA: 12.55 Sell
8-day EMA: 11.94 Buy
20-day EMA: 12.32 Sell
50-day EMA: 12.87 Sell
200-day EMA: 11.76 Buy

Denali Therapeutics Earnings Growth & DNLI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.54 per share, and a decrease next year of $0.03 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.

Denali Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):